Showing 1 - 10 results of 10 for search 'Girish M. Shah', query time: 0.04s
Refine Results
-
1
-
2
-
3
Resistance to PARP-inhibitors in Cancer Therapy by Alicia eMontoni, Mihaela eRobu, Emilie ePouliot, Girish M. Shah
Published 2013-02-01
Article -
4
-
5
-
6
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells by Rashmi G. Shah, Marine A. Merlin, Samuel Adant, Fayçal Zine-Eddine, Jean-Mathieu Beauregard, Girish M. Shah
Published 2021-01-01
Article -
7
Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study. by Nidheesh Dadheech, Abhay Srivastava, Neha Paranjape, Shivika Gupta, Arpita Dave, Girish M Shah, Ramesh R Bhonde, Sarita Gupta
Published 2015-01-01
Article -
8
PARP inhibitors in cancer therapy: Magic bullets but moving targets by Girish M. Shah, Mihaela eRobu, Nupur K. Purohit, Jyotika eRajawat, Lucio eTentori, Grazia eGraziani
Published 2013-11-01
Article -
9
Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates by Fredrik Trulsson, Vyacheslav Akimov, Mihaela Robu, Nila van Overbeek, David Aureliano Pérez Berrocal, Rashmi G. Shah, Jürgen Cox, Girish M. Shah, Blagoy Blagoev, Alfred C. O. Vertegaal
Published 2022-05-01
Article -
10
XPC–PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair by Charlotte Blessing, Katja Apelt, Diana van den Heuvel, Claudia Gonzalez-Leal, Magdalena B. Rother, Melanie van der Woude, Román González-Prieto, Adi Yifrach, Avital Parnas, Rashmi G. Shah, Tia Tyrsett Kuo, Daphne E. C. Boer, Jin Cai, Angela Kragten, Hyun-Suk Kim, Orlando D. Schärer, Alfred C. O. Vertegaal, Girish M. Shah, Sheera Adar, Hannes Lans, Haico van Attikum, Andreas G. Ladurner, Martijn S. Luijsterburg
Published 2022-08-01
Article